[Retracted] Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort

Table 1

Patient demographics and clinical characteristics.

Demographic or characteristic	Primary cohort ()	Validation cohort ()
Male (%)	662 (67.8%)	300 (73.3)	0.039
Age (%)			<0.001
<65year	319 (32.7%)	187 (45.7%)
65-74year	373 (38.2)	145 (35.5%)
≥75year	285 (29.2%)	77 (18.8%)
History of hypertension (%)	721 (73.8%)	352 (86.1%)	<0.001
History of diabetes mellitus (%)	326 (33,4%)	259 (63.3%)	<0.001
Current smoker (%)	439 (44.9%)	310 (75.8%)	<0.001
Initial systolic blood pressure (mmHg, )			0.198
Pattern of ACS (%)			0.006
Unstable angina pectoris	631 (64.6%)	300 (73.3%)
NSTEMI	189 (19.3%)	57 (13.9%)
STEMI	157 (16.1%)	52 (12.7%)
Pattern of AF			<0.001
Paroxysmal	751 (76.9%)	356 (87%)
Persistent	186 (19%)	47 (11.5%)
Permanent	40 (4.1%)	6 (1.5%)
WBC (10^9/L, )			<0.001
Hemoglobin (g/dl, )			0.029
RDW (%, )			<0.001
Platelets (10^9/L, )			0.270
Glucose (mmol/L, )			<0.001
Serum albumin (g/L, )			<0.001
LDL-C (mmol/L, )			0.098
NT-proBNP (%)			<0.001
<300 pg/mL	159 (16.3%)	12 (2.9%)
300-1800 pg/mL	459 (47%)	188 (46%)
1800-18000 pg/mL	338 (34.6%)	203 (49.6%)
>18000 pg/mL	21 (2.1%)	6 (1.5%)
Serum creatinine (umol/L)	91.1837.06		<0.001
GRACE			0.211
CRUSADE			<0.001
CHA2DS2-VASc			<0.001
HAS-BLED			0.929
Follow-up time (month, )			0.507
All-cause death	139 (14.2%)	29 (7.1%)	<0.001